Telematics Governance

Telematics Governance Model

1

EU Telematics Management Board (EU TMB)

Terms of Reference

Composition Role:

Chair (NCA), Vice-Chair (EMA) • 3 HMA

• The EU TMB is a strategic governance body principally responsible for establishing the EU Telematics strategy and then providing strategic governance as to its implementation • The Board operates on behalf of the European Medicines Regulatory Network • The EU TMB reports and advises on IT related topics to the EMA Management Board and Heads of Medicines Agencies (HMA)

2

• 3 EMA Management Board incl. EC and Civil society • 3 EMA • IT Directors Executive Committee -

3 EMA IT

-

3 NCA IT Directors

• 1 EMA IT Liaison Officer

IT Directors Group

Terms of Reference

Role: • The IT Directors Group functions at the tactical level within the

Chair (EMA), Vice-Chair (NCA): rotates

Telematics governance structure and oversees both project and

every 2 years

operational activities

• 1 IT Director per NCA

• The Group is mandated to agree and implement the EU Telematics strategy through a series of programmes and projects • It also provides forum for exchange of ideas, experience and vision

3

Composition

within the network

• 1 EC (DG SANTE) • 3 EMA IT • 1 EMA IT Liaison Officer

IT Directors Executive Committee (IT DEC)

Terms of Reference

Role: • The Committee acts as a core group within the IT Directors Group • It forms part of the EU TMB and provides a liaison between the IT Directors Group and the EU Telematics Management Board • The IT Directors Executive Committee executes the approved vision and strategy as decided upon by the EU TMB and the IT Directors Group

4

Composition Chair (EMA), Vice-Chair (NCA): rotates every 2 years • 3 EMA IT • 3 NCA IT Directors

Telematics Enterprise Architecture Board (TEAB)

Terms of Reference

Composition Role: • The Telematics Enterprise Architecture Board develops and manages the EU Telematics enterprise architecture and the information architecture • It sets standards and provides advice to partners within the Network intended to promote adoption of a common architecture where possible or at least inter-operability where integration is not possible or desirable

5

Chair (EMA) • 4 EMA • 5 NCA • 1 EC (ISA DIGIT)

EU Network Data Board (EU NDB)

Terms of Reference

Composition Role: • EU NDB is an advisory body which reflects the programme agreed by the EU Telematics Management Board (EU TMB) and Head of Medicines Agency (HMA) to manage the policies, principles and quality that will ensure access to accurate and risk-free data and information • The

Board

is

responsible

for

the

development

of

the

data

with international standards, and the quality of master referential data (SPOR)

• 15 NCA • 7 EMA (4 business and 3 IT) • 1 EC • 1 EDQM (European Directorate for the Quality of Medicines)

management strategy, data related standards, including alignment

6

Chair (EMA), Co-chair (NCA)

• 1 Observer

Projects governance •

The aim is to establish structures to assure the joint project delivery of the Telematics portfolio in the most efficient manner possible



Governance of the Telematics projects run by the EMA and NCAs may differ



Requirements gathering and consultation is undertaken through key user groups established for the purpose in the context of the projects’ objectives



After the project closure a key user group may be required to continue overseeing maintenance activities of the new system



There is a continuous interaction between the projects governance and Telematics governance via regular reporting

7

Key user groups Experts groups set up to support the delivery of new Telematics systems (typically projects) and on-going maintenance activities of those systems if required. Composition: EMA, NCAs and Industry (when required)

Programmes

Key User Groups*

eCollaboration

PSUR Repository Maintenance Group*, eSubmission CMB, eAF MG*, Harmonisation Group-H*, Harmonisation Group-V*, eCTD v.4 MG*, Common Repository MG*, Common Repository WG for Veterinary Implementation

Pharmacovigilance

Eudravigilance Expert WG*, Pharmacovigilance Business Team

Clinical Trials

Clinical Trial Programme Subgroups: SG 1*, SG 2, SG 3, SG 4*, SG 5*, SG 6*

Data Integration

EU IDMP/SPOR Task Force Group*, sub-groups S&P*

Veterinary

Consultative group for Veterinary Medicinal Product Data Systems, Consultative Group on Veterinary PhV systems*

* Industry involvement

8

Maintenance Maintenance activities of Telematics systems focus on the delivery of appropriate service levels, coordination of change requests and enhancements control.

Telematics Change Management Board (CMB) Terms of Reference

Composition Chair (EMA), Co-chair (NCA) • 5 NCAs (human & vet) • 7 Service Delivery Managers (5 EMA

Role: •

and 2 NCAs: CESP and CTS)

Assist in the classification of business change requests and review the prioritisation of business change requests across services, including business prioritisation criteria



Propose major changes or development project when these change requests cannot be handled under maintenance activity



9

Review the development and implementation roadmaps for systems life-cycle across services to ensure alignment with the Telematics strategy

Telematics Office The Telematics governance is supported by the Telematics Office which coordinates between the governance bodies.

Role:

10



Ensures appropriate coordination between the Telematics governance bodies



Oversees the link between the Telematics governance, EMA MB and HMA via regular reporting



Provides administrative support to the Telematics governance bodies



Supports implementation of the Telematics roadmap



Acts as a main point of contact for Telematics related enquiries



Assists in relation management with partners and stakeholders and communication and training activities

Telematics governance model - European Medicines Agency

Network. • The EU TMB reports and advises on IT related topics to the EMA ... EU Network Data Board (EU NDB). Role: ... 7 Service Delivery Managers (5 EMA.

812KB Sizes 0 Downloads 200 Views

Recommend Documents

Telematics Enterprise Architecture Board - European Medicines Agency
... Telematics Enterprise Architecture Board is the information technology ... Re-use by all the interested parties of existing systems or services in any of the ...

EU Telematics Management Board - European Medicines Agency
EU Telematics Management Board - European Medicines Agencyfeedproxy.google.com/~r/EmaUpdates/~3/UOZtMxO1_G4/open_document.jsp

Nominations to EU Telematics governance bodies - European ...
EU Telematics Management Board. 3 HMA. Karl Broich (Chair), Jean-Pierre Orand, Audun Haga. 3 EMA Management Board ... EU Network Data Board.

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

dexlansoprazole, lansoprazole - European Medicines Agency
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 13 September 2017. EMA/727763/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance(s): dexlansop